Study of Histological Samples From Patients With Hereditary Haemorrhagic Telangiectasia
Status
Conditions
Details and patient eligibility
About
In this study the investigators will obtain histological samples from people with hereditary haemorrhagic telangiectasia (HHT, also known as Osler-Weber-Rendu Syndrome).
Full description
HHT is an inherited condition that leads to the development of dilated and fragile blood vessels. We propose to obtain small skin samples from patients with HHT in order to analyze the samples using histological methods, and study the properties of vascular endothelial cells derived from patients. We hypothesize that these cells will show differences when compared to normal endothelial cells, which may be confirmed in single time point analyses in histological samples. We anticipate that that these findings may help to explain aspects of the HHT disease phenotype.
Enrollment
Sex
Volunteers
Inclusion criteria
- Patients with Hereditary Haemorrhagic Telangiectasia
Exclusion criteria
- Unable to provide informed consent
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal